JASON EVANS: Open Payments
NPI 1861823635 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,223 in 130 payments from 22 companies in 2025. Trend: 2023 $4,327 · 2024 $3,522 · 2025 $2,223
Food & beverage: $2,223
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $337 |
| Galderma Laboratories, L.P. | 27 | $307 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $193 |
| Incyte Corporation | 5 | $182 |
| PFIZER INC. | 15 | $182 |
| LEO Pharma Inc. | 8 | $174 |
| Organon LLC | 7 | $147 |
| Lilly USA, LLC | 6 | $116 |
| UCB, Inc. | 4 | $98 |
| Biofrontera Inc. | 4 | $92 |
Products named: NEMLUVIO, OPZELURA, SKYRIZI, ADBRY, ILUMYA, RINVOQ, LITFULO, Bimzelx.
Industry payments across UT — which companies pay providers there.
